0001209191-21-057450.txt : 20210923 0001209191-21-057450.hdr.sgml : 20210923 20210923170033 ACCESSION NUMBER: 0001209191-21-057450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210921 FILED AS OF DATE: 20210923 DATE AS OF CHANGE: 20210923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHERMAN JEFFREY W CENTRAL INDEX KEY: 0001230482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 211273109 MAIL ADDRESS: STREET 1: C/O IDM PHARMA, INC. STREET 2: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-21 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001230482 SHERMAN JEFFREY W C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP and Chief Medical Officer Ordinary Shares 2021-09-03 5 G 0 E 4042 0.00 D 9115 D Ordinary Shares 2021-09-03 5 G 0 E 4042 0.00 A 27079 I See footnote Ordinary Shares 2021-09-21 4 M 0 46271 7.61 A 55386 D Ordinary Shares 2021-09-21 4 S 0 46271 110.00 D 9115 D Ordinary Shares 66730 I By Spouse Ordinary Shares 105808 I See footnote Stock Option (Right to Buy) 7.61 2021-09-21 4 M 0 46271 0.00 D 2024-01-02 Ordinary Shares 46271 10729 D The shares are held in the Jeffrey W. Sherman Living Trust. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee. The stock option is fully vested and exercisable. /s/ Miles W. McHugh, Attorney-in-Fact 2021-09-23